NCT00397241View on ClinicalTrials.gov

24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Open-angle Glaucoma
Interventions
DRUG

Drug: dorzolamide/timolol

DRUG

Drug: latanoprost/timolol

DRUG

dorzolamide/timolol and latanoprost

DRUG

placebo (artificial tears)

Trial Locations (1)

546 43

Glaucoma Unit, A University Dept of Ophthalmology, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT00397241 - 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations | Biotech Hunter | Biotech Hunter